Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

What is up with this?

1b- Doxorubicin plus kevetrin, where K will be given 3x week(we think- or maybe at different doses or 2 x a week or 4 x a week), must demonstate efficacy or the trial will be over.

If you, and other board members, want to insist - for some semantic sentimental reasons- that the phase 2 part counts even just a little bit, ok by me, but in name only

1b determines stop or go

or even call it 1B/2-officially of course it is a 1B/2- it matters not a whit

1B is all that really counts anymore